loader
Please Wait
Applying Filters...

Euroapi Company Header Euroapi Company Header

X

Technical details about Ferric Sulfate, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 10028-22-5, Iron(iii) sulfate, Iron persulfate, Ferric persulfate, Iron sesquisulfate, Iron tersulfate
Molecular Formula
Fe2O12S3
Molecular Weight
399.9  g/mol
InChI Key
RUTXIHLAWFEWGM-UHFFFAOYSA-H
FDA UNII
4YKQ1X5E5Y

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
iron(3+);trisulfate
2.1.2 InChI
InChI=1S/2Fe.3H2O4S/c;;3*1-5(2,3)4/h;;3*(H2,1,2,3,4)/q2*+3;;;/p-6
2.1.3 InChI Key
RUTXIHLAWFEWGM-UHFFFAOYSA-H
2.1.4 Canonical SMILES
[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[O-]S(=O)(=O)[O-].[Fe+3].[Fe+3]
2.2 Other Identifiers
2.2.1 UNII
4YKQ1X5E5Y
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ferric Sulfate Heptahydrate

2. Ferric Sulfate Hexahydrate

3. Ferric Sulfate Hydrate

4. Ferric Sulfate Monohydrate

5. Ferric Sulfate Nonahydrate

6. Ferric Sulfate Tetrahydrate

7. Ferric Sulfate Trihydrate

8. Ferric Sulfate, Basic

9. Polyferric Sulfate

2.3.2 Depositor-Supplied Synonyms

1. 10028-22-5

2. Iron(iii) Sulfate

3. Iron Persulfate

4. Ferric Persulfate

5. Iron Sesquisulfate

6. Iron Tersulfate

7. Iron(3+) Sulfate

8. Diiron Tris(sulphate)

9. Diiron Trisulfate

10. Ferric Tersulfate

11. Ferric Sesquisulfate

12. Iron(3+);trisulfate

13. Iron Sulfate (fe2(so4)3)

14. 4ykq1x5e5y

15. Coquimbite Mineral

16. Iron Sulfate (2:3)

17. Ccris 7885

18. Iron(3+) Sulfate, (2:3)

19. Hsdb 6311

20. Einecs 233-072-9

21. Mfcd00011007

22. Unii-4ykq1x5e5y

23. Sulfuric Acid, Iron(3+) Salt

24. Iron-s-hydrate

25. Iron(iii)sulphate

26. Ferric Sulfate (usp)

27. Sulfuric Acid,iron Salt

28. Iron(iii) Sulfate(vi)

29. Diiron Trissulfate Hydrate

30. Polyferric Sulfate(spfs)

31. Diiron Trissulphate Hydrate

32. Ec 233-072-9

33. Iron(iii) Sulphate Hydrate

34. Ferric Sulfate [mi]

35. Ferric Sulfate [inci]

36. Ferric Sulfate Anhydrous

37. Dtxsid5029712

38. Ferric Sulfate [who-dd]

39. Chebi:53438

40. Iron(iii) Sulfate (fe2(so4)3)

41. Ferric Sulfate Hydrate 500gm

42. Akos015903761

43. Ft-0627289

44. D08922

45. Q409021

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 399.9 g/mol
Molecular Formula Fe2O12S3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count12
Rotatable Bond Count0
Exact Mass399.725060 g/mol
Monoisotopic Mass399.725060 g/mol
Topological Polar Surface Area266 Ų
Heavy Atom Count17
Formal Charge0
Complexity62.2
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count5
4 Drug and Medication Information
4.1 Therapeutic Uses

Seventy primary molar teeth, carious exposed, symptom free, without any sign of root resorption in children aged from 3 to 6 years (main age 4.3 yr) were treated with conventional pulpotomy procedures. Ferric sulfate 15.5% solution (applied for 15 second for 35 teeth) and formocresol solution (five minute procedure of Buckley's formula for next 35 teeth) have been used as pulpotomy agents. In both groups, pulp stumps were covered with zinc-oxide eugenol paste. Permanent restorations were stainless steel crowns. Clinical check up was every three-months and radiographic follow-up time was six and twenty months after treatment. Our results within this period revealed 100% clinical success rate in both groups. Radiographic success rate was in both groups 97.2%, while in 2.8% cases has shown internal root resorption.

PMID:11314410 Ibricevic H, al-Jame Q; J Clin Pediatr Dent 24 (4): 269-72 (2000)


The hemostatic efficacy, as well as the cardiovascular effects, of two hemostatic agents currently used during endodontic surgery was examined. The hemostatic agents used were epinephrine pellets (Racellet pellets) or 20% ferric sulfate (Viscostat). Patients were assigned to one of two experimental groups. Blood pressure and pulse rate were recorded pre- and postoperatively and at three additional times during the surgery (root-end resection, root-end preparation, and filling). The adequacy of hemostasis was rated by the surgical operator. Results indicated that there is no significant change in cardiovascular effects when using either of these hemostatic agents. Except in one case where ferric sulfate was the agent, both agents produced surgical hemostasis that allowed for a dry field for root-end filling.

PMID:12043873 Vickers FJ et al; J Endod 28 (4): 322-3 (2002)


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Iron [CS]
5.2 Absorption, Distribution and Excretion

The bioavailability of ferrous and ferric iron following cecal infusion was compared by assessing the hemoglobin regeneration method in ileally fistulated anemic rats. Rats were fed an iron-deficient diet (8 mg Fe/kg diet) for 14 days after recovery from surgery. The anemic rats were then divided into three groups of 11 rats. Group 1 (control) was fed an iron-adequate diet (45 mg Fe/kg diet) and infused with NaCl solution (150 mM). Group 2 and 3 were fed an iron-deficient diet and infused with ferrous sulfate [Fe(II)] suspension or ferric sulfate [Fe(III)] solution (800 ppm as Fe, pH 6.8) to provide the same amount of iron as that consumed one day before by the control group. NaCl, Fe(II) and Fe(III) were infused through the fistula as two times (1000 hr and 1800 hr) for 14 days. The volume of NaCl infused was about equal to the volume of Fe(II) suspension and Fe(III) solution infused. Hemoglobin regeneration efficiency, hematocrit, plasma iron concentration, transferrin saturation, total iron-binding capacity, iron contents in organs (liver, spleen and kidney), body weight gain and food intake were almost the same among groups.

Kiyoshi E, Jun O; Nutr Res 15 (6): 889-897 (1995)


Post Enquiry
POST ENQUIRY